home / stock / abvc / abvc articles
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Thursday. The Dow traded down 0.29% to 32,938...
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 231.6% to $2.8190 after the company announced it entered into a term sheet to license t...
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.36% to 32...
ABVC Biopharma Inc (NASDAQ: ABVC) shares are trading higher by 309% to $3.48 Thursday morning after the company announced it entered into a term sh...
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This ind...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- After successfully completing Phase II clinical trials for their medication to treat Major Depressive Disorder, ABVC BioPharma Inc. and AiBtl BioPharma Inc. are now embarking on a groundbreaking clinical study focused on Depression in Cancer Patients. This new study will i...
FREMONT, CA - ( NewMediaWire ) - July 9, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that after successful Phase II c...
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...